India's drug regulator Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide injection) manufactured by Danish pharma company Novo Nordisk for use in adults with type 2 diabetes. According to sources, Ozempic, the once... [3778 chars].. reed more
